App-Quantinova.ai

Acute Painful Neuropathy in a Teenager with Type 1 Diabetes (T1D) and Eating Disorders

Maria Louraki - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic retinopathy

N/A

Short-Term Use of Continuous Glucose Monitoring System in Paediatric Patients with Type 1 Diabetes Mellitus and Correlation with Short-Term Improvement in Glycaemic Control

Monica Bianco - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Metabolic Control and Glycemic Variability in Pediatric Patients with Type 1 Diabetes in Multiple Daily Injections Therapy Using Automated Bolus Calculator Glucometer

Marta Murillo-Valles - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

A Case of DEND (Developmental Delay, Epilepsy, and Neonatal Diabetes) Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea Therapy

Ja Hye Kim - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Permanent neonatal diabetes mellitus

sulfonylureas

Two Permanent Neonatal Diabetes Mellitus Cases due to Mutation in abcc8 Genes in Vietnam: Clinical Features and Long Term Outcome in Treating by Sulfonylurea (2008 2014)

Phuong Khanh Nguyen - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Permanent neonatal diabetes mellitus

sulfonylureas

The Missing Link in Neonatal Diabetes

Irene Pilar Fernandez Viseras - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

Actrapid

Particularites de la prise en charge du diabete Type 1 chez des enfants dont la revelation est survenue avant -age de five ans

Mazari Wafaa - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

ReVele

School Aged Presentation of Diabetes Mellitus Type 1 with Repeat Hyperglycaemia, Positive Pancreatic Autoimmunity and Related Genetic Risks

Ana Dolores Alcalde - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Type 1 diabetes mellitus

N/A

Liver Steatosis in Obese Children Courses with Enhanced Insulin Resistance and Dyslipidaemia, Which are Influenced by Gender, Puberty, Race and Body Fat Distribution

Gabriel A Martos-Moreno - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Higher Hb1Ac in Obese Prader-Willi Syndrome Patients vs Obese Controls

Caroline Passone - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Prader-willi syndrome

N/A

Does Vitamin D Influence Energy Metabolism in Children and Adolescents?

Anna Wedrychowicz - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

Ergocalciferol

Experience with Sleeve Gastrectomy in Adolescent Obese Subjects and in Prader-Willi Syndrome

Danilo Fintini - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prader-willi syndrome

N/A

Are Short Children with Low GH Secretion Metabolically Different from Children of Normal Height?

Anders Tidblad - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

The Blood Oxidant System and Insulin Resistance in Girls with Turner Syndrome after 1 Year of GH Therapy

Maria Pankratova - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Turner syndrome

Superoxide dismutase

Experience in Insulin Pump Therapy in the Treatment of Neonatal Diabetes

Tlif Asiet - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hyperglycemia

SureLac

Reduced Humanin Levels in Children with Type 1 Diabetes Mellitus

Maria Isabel Hernandez - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Clinical management of fragile bone in type 2 diabetes

Eugene McCloskey - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Orthostatic hypotension

Thiazolidinedione

Continuous glucose monitoring systems

Tadej Battelino - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Phenotypic characteristic of type 1 diabetic women with polycystic ovary syndrome

Agnieszka Adamska - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Polycystic Ovary Syndrome

N/A

Local administration of non-diabetic MSCs to diabetic femoral fractures enhances callus remodelling and deposition of reparative bone

Xi Zhe Chen - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Filters

4759 Abstracts